Breaking News From Pharma & Bio Ingredients Subscribe via RSS Subscribe via RSS



Meer Appointed Chief Financial Officer of Columbia Laboratories


Posted on 2006-12-08 08:47:00



Columbia Laboratories, Inc. has appointed James A. Meer to the position of senior vice president, chief financial officer and treasurer, succeeding David L. Weinberg, who is leaving to pursue other opportunities. Mr. Meer will direct and oversee the financial management, accounting and investor relations activities of the company, effective immediately.

Robert S. Mills, Columbia's president and chief executive officer, stated, "We are pleased to have Jim fill this important role, as he brings with him a strong financial and industry transaction background as well as a demonstrated ability to communicate effectively with the investment community. We believe the depth and breadth of his experiences have prepared him well for his responsibilities at Columbia, and look forward to his contributions as we execute our strategic plan to become a leading player in the women's reproductive healthcare market."

Mr. Meer has over 35 years of financial experience in both privately and publicly held companies, of which 15 years were in the life sciences industry. He most recently served as senior vice president, chief financial officer, secretary and treasurer of Pharmos Corporation, a NASDAQ-traded biotechnology company. Prior to joining Pharmos, Mr. Meer was a consultant to specialty pharmaceutical and biotech firms providing strategic and financial advice. He previously served eight years as vice president and treasurer of Schein Pharmaceutical, Inc. where he was responsible for capital formation, including a successful IPO, strategic planning and investor relations. He also held senior financial positions with public companies including EnviroSource, Inc., John Labatt Ltd. and General Host Corporation. Mr. Meer holds an MBA degree from Pace University and a BA degree in Economics from Rutgers College.


NEWS ARCHIVES

2008

2007

2006

2005

2004

NEWSLETTER SIGNUP